The Likelihood of Heterogeneity or Additional Mutation to Compromise Targeting of KRAS G12C

被引：0
|
作者：
Cannataro, V. [1 ]
Gaffney, S. [1 ]
Stender, C. [1 ]
Zhao, Z. [1 ]
Philips, M. [2 ]
Greenstein, A. [3 ]
Townsend, J. [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
[2] NYU, New York, NY USA
[3] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 08期
关键词：
D O I：
10.1016/j.jtho.2017.06.029
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1538 / S1538
页数：1
相关论文
共 50 条
  • [1] Targeting KRAS G12C mutation in lung adenocarcinoma
    Rohatgi, Anjali
    Govindan, Ramaswamy
    LUNG CANCER, 2022, 165 : 28 - 33
  • [2] Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C
    Vincent L. Cannataro
    Stephen G. Gaffney
    Carly Stender
    Zi-Ming Zhao
    Mark Philips
    Andrew E. Greenstein
    Jeffrey P. Townsend
    Oncogene, 2018, 37 : 2444 - 2455
  • [3] Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C
    Cannataro, Vincent L.
    Gaffney, Stephen G.
    Stender, Carly
    Zhao, Zi-Ming
    Philips, Mark
    Greenstein, Andrew E.
    Townsend, Jeffrey P.
    ONCOGENE, 2018, 37 (18) : 2444 - 2455
  • [4] Targeting the KRAS G12C Mutation in Patients With Advanced Solid Tumors
    Hong, David S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 612 - 614
  • [5] KRAS G12C mutation is not undruggable anymore
    Rodrigues, Manuel
    BULLETIN DU CANCER, 2020, 107 (02) : 145 - 145
  • [6] Targeting KRAS G12C with Covalent Inhibitors
    Ostrem, Jonathan M. L.
    Shokat, Kevan M.
    ANNUAL REVIEW OF CANCER BIOLOGY, 2022, 6 : 49 - 64
  • [7] Targeting the KRAS G12C Mutation in NSCLC For a early, deep and sustained Remission
    Fessler, Beate
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (04) : 230 - 230
  • [8] Precision medicine in metastatic colorectal cancer: targeting KRAS G12C mutation
    Aparicio, Jorge
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 9
  • [9] Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors
    Choi, Yoonha
    Dharia, Neekesh V.
    Jun, Tomi
    Chang, Julie
    Royer-Joo, Stephanie
    Yau, Kenneth K.
    Assaf, Zoe J.
    Aimi, Junko
    Sivakumar, Smruthy
    Montesion, Meagan
    Sacher, Adrian
    LoRusso, Patricia
    Desai, Jayesh
    Schutzman, Jennifer L.
    Shi, Zhen
    CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3788 - 3797
  • [10] Targeting KRAS G12C mutations in colorectal cancer
    Zhao, Ming-He
    Wu, Ai-Wen
    GASTROENTEROLOGY REPORT, 2023, 11
12345